Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial

被引:0
|
作者
Mant, Jonathan [1 ]
Modi, Rakesh N. [1 ]
Dymond, Andrew [1 ]
Armstrong, Natalie [2 ]
Burt, Jenni [3 ]
Calvert, Peter [4 ]
Cowie, Martin [5 ]
Ding, Wern Yew [4 ]
Edwards, Duncan [1 ]
Freedman, Ben [6 ]
Griffin, Simon J. [7 ,8 ]
Hoare, Sarah [9 ]
Hobbs, F. D. Richard [10 ]
Johnson, Rachel [11 ]
Kaptoge, Stephen [12 ]
Lip, Gregory Y. H. [4 ,13 ]
Lobban, Trudie [14 ]
Lown, Mark [15 ]
Lund, Jenny [16 ]
McManus, Richard J. [10 ]
Mills, Mark T. [4 ]
Morris, Stephen [9 ]
Powell, Alison [17 ]
Proietti, Riccardo [4 ]
Sutton, Stephen [9 ]
Sweeting, Mike [12 ]
Thom, Howard [11 ]
Williams, Kate [1 ]
机构
[1] Univ Cambridge, Primary Care Unit, Strangeways Res Lab, Cambridge, England
[2] Univ Leicester, Dept Populat Hlth Sci, Leicester, England
[3] THIS Labs, Cambridge, England
[4] Liverpool Heart & Chest Hosp NHS Fdn Trust, Liverpool, England
[5] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, London, England
[6] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia
[7] Univ Cambridge, Inst Publ Hlth, Primary Care Unit, Cambridge, England
[8] MRC Epidemiol Unit, Cambridge, England
[9] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England
[10] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[11] Univ Bristol, Bristol, England
[12] Cambridge Biomed Campus, Cambridge, England
[13] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
[14] Arrhythmia Alliance & AF Assoc, Stratford Upon Avon, England
[15] Univ Southampton, Sch Primary Care Populat Sci & Med Educ, Southampton, England
[16] Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England
[17] Univ Cambridge, THIS Inst, Cambridge, England
来源
BMJ OPEN | 2024年 / 14卷 / 04期
基金
美国国家卫生研究院; 英国惠康基金;
关键词
Primary Care; Mass Screening; Stroke; Randomized Controlled Trial; CARDIOLOGY; COGNITIVE DECLINE; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction There is a lack of evidence that the benefits of screening for atrial fibrillation (AF) outweigh the harms. Following the completion of the Screening for Atrial Fibrillation with ECG to Reduce stroke (SAFER) pilot trial, the aim of the main SAFER trial is to establish whether population screening for AF reduces incidence of stroke risk.Methods and analysis Approximately 82 000 people aged 70 years and over and not on oral anticoagulation are being recruited from general practices in England. Patients on the palliative care register or residents in a nursing home are excluded. Eligible people are identified using electronic patient records from general practices and sent an invitation and consent form to participate by post. Consenting participants are randomised at a ratio of 2:1 (control:intervention) with clustering by household. Those randomised to the intervention arm are sent an information leaflet inviting them to participate in screening, which involves use of a handheld single-lead ECG four times a day for 3 weeks. ECG traces identified by an algorithm as possible AF are reviewed by cardiologists. Participants with AF are seen by a general practitioner for consideration of anticoagulation. The primary outcome is stroke. Major secondary outcomes are: death, major bleeding and cardiovascular events. Follow-up will be via electronic health records for an average of 4 years. The primary analysis will be by intention-to-treat using time-to-event modelling. Results from this trial will be combined with follow-up data from the cluster-randomised pilot trial by fixed-effects meta-analysis.Ethics and dissemination The London-Central National Health Service Research Ethics Committee (19/LO/1597) provided ethical approval. Dissemination will include public-friendly summaries, reports and engagement with the UK National Screening Committee.Trial registration number ISRCTN72104369.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Perioperative bridging anticoagulation for atrial fibrillation—the first randomised controlled trial
    James Matthew Wight
    Malachy Oliver Columb
    Perioperative Medicine, 5 (1)
  • [42] Acupressure to improve sleep quality of older people in residential aged care: a randomised controlled trial protocol
    Nant Thin Thin Hmwe
    Graeme Browne
    Lyndall Mollart
    Viv Allanson
    Sally Wai-Chi Chan
    Trials, 21
  • [43] Quality of life after screening for atrial fibrillation: a substudy from a randomised screening trial
    Kongebro, E.
    Kronborg, C.
    Haugan, K. J.
    Graff, C.
    Hoejberg, S.
    Olesen, M.
    Krieger, D.
    Brandes, A.
    Koeber, L.
    Svendsen, J. H.
    Diederichsen, S. Z.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] Acupressure to improve sleep quality of older people in residential aged care: a randomised controlled trial protocol
    Hmwe, Nant Thin Thin
    Browne, Graeme
    Mollart, Lyndall
    Allanson, Viv
    Chan, Sally Wai-Chi
    TRIALS, 2020, 21 (01)
  • [45] A study protocol for a randomised controlled trial of ice to reduce the pain of immunisation
    Ediriweera, Yashodha
    Banks, Jennifer
    Hall, Leanne M.
    Heal, Clare
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (03) : 173 - 177
  • [46] Opportunistic screening for atrial fibrillation versus detecting symptomatic patients aged 65 years and older: A cluster-controlled clinical trial
    Gonzalez Blanco, Virginia
    Angel Perula de Torres, Luis
    Martin Rioboo, Enrique
    Martinez Adell, Miguel Angel
    Parras Rejano, Juan Manuel
    Gonzalez Lama, Jesus
    Ruiz Moruno, Javier
    Martin Alvarez, Remedios
    Fernandez Garcia, Jose Angel
    Ruiz de Castroviejo, Joaquin
    Roldan Villalobos, Ana
    Ruiz Moral, Roger
    MEDICINA CLINICA, 2017, 148 (01): : 8 - 15
  • [47] Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
    Shoamanesh, Ashkan
    Field, Thalia S.
    Coutts, Shelagh B.
    Sharma, Mukul
    Gladstone, David
    Hart, Robert G.
    Boriani, Giuseppe
    Wright, David J.
    Sticherling, Christian
    Birnie, David H.
    Gold, Michael R.
    Erath, Julia W.
    Kutyifa, Valentina
    Mian, Rajibul
    Benz, Alexander P.
    Granger, Christopher B.
    Mcintyre, William F.
    Connolly, Stuart J.
    Nielsen, Jens Cosedis
    Alings, Marco
    Rivard, Lena
    Lopes, Renato
    Healey, Jeff S.
    LANCET NEUROLOGY, 2025, 24 (01): : 140 - 151
  • [48] Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial
    Steven B. Uittenbogaart
    Nicole Verbiest-van Gurp
    Petra M. G. Erkens
    Wim A. M. Lucassen
    J. André Knottnerus
    Bjorn Winkens
    Henk C. P. M. van Weert
    Henri E. J. H. Stoffers
    Trials, 16
  • [49] Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial
    Uittenbogaart, Steven B.
    Verbiest-Van Gurp, Nicole
    Erkens, Petra M. G.
    Lucassen, Wim A. M.
    Knottnerus, J. Andre
    Winkens, Bjorn
    van Weert, Henk C. P. M.
    Stoffers, Henri E. J. H.
    TRIALS, 2015, 16
  • [50] The DESPATCH study: Delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare
    Gattellari, Melina
    Oldmeadow, Christopher
    Pelazzi, Kerrin
    Leung, Dominic
    Zwar, Nicholas
    Worthington, John
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 27 - 27